Neuronetics, Inc. (STIM)
1.42
-0.16
(-10.13%)
USD |
NASDAQ |
Feb 13, 16:00
1.46
+0.04
(+2.82%)
After-Hours: 20:00
Neuronetics Shareholders Equity (Quarterly) : 27.36M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 598.36M |
| Plus Therapeutics, Inc. | 5.054M |
| Atossa Therapeutics, Inc. | 49.79M |
| Abeona Therapeutics, Inc. | 171.23M |
| Cell Source, Inc. | -18.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 145.46M |
| Total Liabilities (Quarterly) | 114.10M |
| Debt to Equity Ratio | 3.317 |
| Current Ratio | 2.242 |
| Net Debt Paydown Yield | -3.01% |